This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Biologicals S.a.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Innovations by Marcelle Van Mechelen
Introduction
Marcelle Van Mechelen is an accomplished inventor based in Wagnelee, Belgium. He has made significant contributions to the field of immunology, particularly in the area of nucleic acid vaccination. His innovative approach aims to enhance immune responses, which is crucial for developing effective vaccines.
Latest Patents
Marcelle holds a patent for a method to enhance an immune response of nucleic acid vaccination. This invention provides a method to enhance an immune response by the simultaneous administration of a polynucleotide and a polypeptide of interest. His work in this area has the potential to improve vaccine efficacy and patient outcomes.
Career Highlights
Marcelle Van Mechelen is associated with SmithKline Beecham Biologicals S.A., a company known for its focus on vaccine development and biotechnology. His role in this organization has allowed him to contribute to groundbreaking research and development in immunology.
Collaborations
Some of his notable coworkers include Wilfried Dalemans and Claudine Bruck, who have also made significant contributions to the field. Their collaborative efforts have further advanced the research and development of innovative vaccination methods.
Conclusion
Marcelle Van Mechelen's work exemplifies the importance of innovation in the field of immunology. His patent and contributions to vaccine development highlight the potential for advancements that can significantly impact public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile